LONDON, May 07, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (the “ Company” or “Small Pharma”), an IP-led neuropharmaceutical company, is pleased to announce an update on its patent portfolio since the filing of its filing statement on April 23, 2021. The Company announces that it has received an in order for grant notice in the United Kingdom for one of its patents related to…


Previous articlePsilocybin and the Will to Live
Next articlePTSF58 – Liberty, The Power of Therapy, and Mushrooms in Maine